×
About 48,330 results

ALLMedicine™ Bipolar Disorder Center

Research & Reviews  22,767 results

The impact of caffeine consumption on clinical symptoms in patients with bipolar disord...
https://doi.org/10.1111/bdi.12990
Bipolar Disorders; Frigerio S, Strawbridge R et. al.

Sep 19th, 2020 - In healthy populations, caffeine appears to have beneficial effects on health; however, patients with bipolar disorder (BD) are routinely advised to limit caffeine use in psychoeducation programmes. We aimed to examine all literature reporting whe...

A Vote for the Full Ticket.
https://doi.org/10.1111/bdi.12989
Bipolar Disorders; Rego SA, Alpert JE

Sep 19th, 2020 - Based on data from the 1997-2016 National Ambulatory Care Surveys, dramatic changes have occurred in the treatment practices of psychiatrists caring for patients with bipolar disorder (1). These trends include an increase in the prescription of an...

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk sco...
https://doi.org/10.1038/s41398-020-00996-y
Translational Psychiatry; Coombes BJ, Markota M et. al.

Sep 19th, 2020 - Bipolar disorder (BD) has high clinical heterogeneity, frequent psychiatric comorbidities, and elevated suicide risk. To determine genetic differences between common clinical sub-phenotypes of BD, we performed a systematic polygenic risk score (PR...

Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
https://doi.org/10.1097/WNF.0000000000000407
Clinical Neuropharmacology; Lorettu L, Carpita B et. al.

Sep 18th, 2020 - Although lithium is widely used as a first-line treatment for mood disorders, its mood-stabilizing effects remain not fully understood. A growing body of data are stressing that lithium seems to show broader properties, including neuroprotective e...

Little Agreement on Treating Residual Bipolar Disorder Symptoms in a Child.
https://doi.org/10.4088/PCC.19m02574
The Primary Care Companion for CNS Disorders; Post RM, Rowe M et. al.

Sep 17th, 2020 - There is a paucity of studies on treatment of childhood-onset bipolar disorder and its associated comorbidities, which leads to a wide diversity of opinion on choice and sequencing of treatment options. From December 2018 to January 2019, a graphi...

see more →

Guidelines  63 results

Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression
https://www.allergan.com/news/news/thomson-reuters/allergan-and-gedeon-richter-receive-u-s-fda-approv.aspx

May 27th, 2019 - Allergan plc (NYSE: AGN) and Gedeon Richter Plc. today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for VRAYLAR® (cariprazine) for expanded use to treat depressive episodes ass...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of European Psychiatrists; Stubbs B, Vancampfort D et. al.

Sep 27th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
https://onlinelibrary.wiley.com/doi/epdf/10.1111/bdi.12609
Yatham,L.,et al

Apr 20th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously pub-lished treatment guidelines for bipolar disorder in 2005, along with international com-mentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were...

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947163
Bipolar Disorders; Yatham LN, Kennedy SH et. al.

Mar 14th, 2018 - The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were p...

Methodological recommendations for cognition trials in bipolar disorder by the Internat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282834
Bipolar Disorders; Miskowiak KW, Burdick KE et. al.

Sep 12th, 2017 - To aid the development of treatment for cognitive impairment in bipolar disorder, the International Society for Bipolar Disorders (ISBD) convened a task force to create a consensus-based guidance paper for the methodology and design of cognition t...

see more →

Drugs  859 results see all →

Clinicaltrials.gov  23,773 results

The impact of caffeine consumption on clinical symptoms in patients with bipolar disord...
https://doi.org/10.1111/bdi.12990
Bipolar Disorders; Frigerio S, Strawbridge R et. al.

Sep 19th, 2020 - In healthy populations, caffeine appears to have beneficial effects on health; however, patients with bipolar disorder (BD) are routinely advised to limit caffeine use in psychoeducation programmes. We aimed to examine all literature reporting whe...

A Vote for the Full Ticket.
https://doi.org/10.1111/bdi.12989
Bipolar Disorders; Rego SA, Alpert JE

Sep 19th, 2020 - Based on data from the 1997-2016 National Ambulatory Care Surveys, dramatic changes have occurred in the treatment practices of psychiatrists caring for patients with bipolar disorder (1). These trends include an increase in the prescription of an...

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk sco...
https://doi.org/10.1038/s41398-020-00996-y
Translational Psychiatry; Coombes BJ, Markota M et. al.

Sep 19th, 2020 - Bipolar disorder (BD) has high clinical heterogeneity, frequent psychiatric comorbidities, and elevated suicide risk. To determine genetic differences between common clinical sub-phenotypes of BD, we performed a systematic polygenic risk score (PR...

Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
https://doi.org/10.1097/WNF.0000000000000407
Clinical Neuropharmacology; Lorettu L, Carpita B et. al.

Sep 18th, 2020 - Although lithium is widely used as a first-line treatment for mood disorders, its mood-stabilizing effects remain not fully understood. A growing body of data are stressing that lithium seems to show broader properties, including neuroprotective e...

Little Agreement on Treating Residual Bipolar Disorder Symptoms in a Child.
https://doi.org/10.4088/PCC.19m02574
The Primary Care Companion for CNS Disorders; Post RM, Rowe M et. al.

Sep 17th, 2020 - There is a paucity of studies on treatment of childhood-onset bipolar disorder and its associated comorbidities, which leads to a wide diversity of opinion on choice and sequencing of treatment options. From December 2018 to January 2019, a graphi...

see more →

News  817 results

We are physicians, not providers, and we treat patients, not clients!
https://www.mdedge.com/psychiatry/article/216093/we-are-physicians-not-providers-and-we-treat-patients-not-clients/page/0/2?channel=41022

Feb 3rd, 2020 - Patients, not clients We should also emphasize that our suffering and medically ill patients with serious neuropsychiatric disorders such as schizophrenia, bipolar disorder, depression, panic disorder, or obsessive-compulsive disorder are patients.

Stimulant Medication Prescribing Practices Within a VA Health Care System
https://www.mdedge.com/fedprac/article/216490/mixed-topics/stimulant-medication-prescribing-practices-within-va-health-care/page/0/3?channel=112

Jan 31st, 2020 - In some cases, stimulant medications were discontinued by a prescriber secondary to a worsening of another mental health condition. More than half of the participants in this study had an anxiety disorder diagnosis.

Family-focused therapy linked to longer remissions in youth at risk for bipolar disorder
https://www.mdedge.com/jcomjournal/article/216077/bipolar-disorder/family-focused-therapy-linked-longer-remissions-youth?channel=271
Jennie Smith

Jan 24th, 2020 - A 4-month intensive program of family-focused therapy worked better than a less-intensive program in delaying new mood episodes among young people at risk of developing bipolar disorder, new research shows. “This study extends the results of other.

The paranoid business executive
https://www.mdedge.com/psychiatry/article/214889/bipolar-disorder/paranoid-business-executive/page/0/5?channel=190

Jan 2nd, 2020 - Related Resources Rakofsky JJ, Dunlop BW. Nothing to sneeze at: Upper respiratory infections and mood disorders.

Schizophrenia, bipolar disorder associated with increased risk of secondary TD
https://www.mdedge.com/psychiatry/article/214296/movement-disorders/schizophrenia-bipolar-disorder-associated-increased?channel=293
Lucas Franki

Dec 13th, 2019 - Psychiatric inpatients, particularly those with schizophrenia or bipolar disorder, have both a greater risk of having a secondary diagnosis of tardive dyskinesia and having worse illness when tardive dyskinesia is also present, according to result.

see more →

Patient Education  51 results see all →